Comments
Drug maker Sanofi India is announcing its financial results for the quarter ended December 31, 2013 on Tuesday. Since taking support at ₹2,250 early last week, the stock has advanced 7 per cent in anticipation of good results. Its 200-day moving average also provided a base at this support level. However, the stock is facing an important resistance level ahead at ₹2,800. A positive surprise can lift the share to ₹2,900. Else, shares of Sanofi could decline to ₹2,600 or ₹2,550 in the near-term.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.